These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9058850)

  • 1. The ESVEM trial: impact on treatment of ventricular tachyarrhythmias. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiter MJ
    Pacing Clin Electrophysiol; 1997 Feb; 20(2 Pt 2):468-77. PubMed ID: 9058850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implications of the Electrophysiologic Study versus Electrocardiographic Monitoring trial for controlling ventricular tachycardia and fibrillation.
    Reiffel JA
    Am J Cardiol; 1996 Aug; 78(4A):34-40. PubMed ID: 8780327
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative efficacy of sotalol and class I antiarrhythmic agents in patients with ventricular tachycardia or fibrillation: results of the Electrophysiology Study Versus Electrocardiographic Monitoring (ESVEM) Trial.
    Klein RC
    Eur Heart J; 1993 Nov; 14 Suppl H():78-84. PubMed ID: 8293756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electrophysiologic Study versus Electrocardiographic Monitoring (ESVEM): a critical appraisal.
    Prystowsky EN
    Control Clin Trials; 1996 Jun; 17(3 Suppl):28S-36S. PubMed ID: 8877265
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of Holter monitor and electrophysiologic study methods and efficacy criteria on the outcome of patients with ventricular tachycardia and ventricular fibrillation in the ESVEM trial.
    Reiffel JA; Reiter MJ; Freedman RA; Mann D; Huang SK; Hahn E; Hartz V; Mason J;
    Prog Cardiovasc Dis; 1996; 38(5):359-70. PubMed ID: 8604440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sotalol for ventricular tachyarrhythmias: beta-blocking and class III contributions, and relative efficacy versus class I drugs after prior drug failure. ESVEM Investigators. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiffel JA; Hahn E; Hartz V; Reiter MJ
    Am J Cardiol; 1997 Apr; 79(8):1048-53. PubMed ID: 9114762
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A summary and assessment of the findings and conclusions of the ESVEM trial.
    Mason JW; Marcus FI; Bigger JT; Lazzara R; Reiffel JA; Reiter MJ; Mann D
    Prog Cardiovasc Dis; 1996; 38(5):347-58. PubMed ID: 8604439
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cost of initial therapy in the Electrophysiological Study Versus ECG Monitoring trial (ESVEM).
    Omoigui NA; Marcus FI; Mason JW; Hahn EA; Hartz VL; Hlatky MA
    Circulation; 1995 Feb; 91(4):1070-6. PubMed ID: 7850943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interpretation of the results of the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) study: electrocardiographic monitoring advocates' view.
    d'Avila A; Fenelon G; Nellens P; Brugada P
    Coron Artery Dis; 1994 Aug; 5(8):677-81. PubMed ID: 8000620
    [No Abstract]   [Full Text] [Related]  

  • 10. Contemporary clinical trials in ventricular tachycardia and fibrillation: implications of ESVEM, CASCADE, and CASH for clinical management.
    Anderson JL
    J Cardiovasc Electrophysiol; 1995 Oct; 6(10 Pt 2):880-6. PubMed ID: 8548109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reproducibility of drug efficacy predictions by Holter monitoring in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. ESVEM Investigators.
    Reiter MJ; Karagounis LA; Mann DE; Reiffel JA; Hahn E; Hartz V
    Am J Cardiol; 1997 Feb; 79(3):315-22. PubMed ID: 9036751
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insights into the Electrophysiology Study Versus Electrocardiographic Monitoring Trial: its programmed stimulation protocol may introduce bias when assessing long-term antiarrhythmic drug therapy.
    Biblo LA; Carlson MD; Waldo AL
    J Am Coll Cardiol; 1995 Jun; 25(7):1601-4. PubMed ID: 7759711
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interpretation of the results of the Electrophysiologic Study Versus Electrocardiographic Monitoring (ESVEM) study: programmed ventricular stimulation advocates view.
    Mitchell LB; Wyse DG
    Coron Artery Dis; 1994 Aug; 5(8):671-6. PubMed ID: 8000619
    [No Abstract]   [Full Text] [Related]  

  • 14. Significance and incidence of concordance of drug efficacy predictions by Holter monitoring and electrophysiological study in the ESVEM Trial. Electrophysiologic Study Versus Electrocardiographic Monitoring.
    Reiter MJ; Mann DE; Reiffel JE; Hahn E; Hartz V
    Circulation; 1995 Apr; 91(7):1988-95. PubMed ID: 7895357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electrocardiographic predictors in the ESVEM trial: unsustained ventricular tachycardia, heart period variability, and the signal-averaged electrocardiogram.
    Anderson KP; Bigger JT; Freedman RA
    Prog Cardiovasc Dis; 1996; 38(6):463-88. PubMed ID: 8638028
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The ESVEM trial. Electrophysiologic Study Versus Electrocardiographic Monitoring for selection of antiarrhythmic therapy of ventricular tachyarrhythmias. The ESVEM Investigators.
    Circulation; 1989 Jun; 79(6):1354-60. PubMed ID: 2655967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent insights in programmed electrical stimulation for the management of sustained ventricular arrhythmias.
    Wood M; Stambler B; Ellenbogen K
    Curr Opin Cardiol; 1994 Jan; 9(1):3-11. PubMed ID: 8199368
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evolving role of sotalol in the management of ventricular tachyarrhythmias.
    O'Callaghan PA; McGovern BA
    Am J Cardiol; 1996 Aug; 78(4A):54-60. PubMed ID: 8780329
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical significance of syncope in the electrophysiologic study versus electrocardiographic monitoring (ESVEM) trial. The ESVEM Investigators.
    Olshansky B; Hahn EA; Hartz VL; Prater SP; Mason JW
    Am Heart J; 1999 May; 137(5):878-86. PubMed ID: 10220637
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.